Who Supplies Tobramycin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Tobramycin exports, with 283+ registered manufacturers shipping to buyers across 134+ countries — yet a handful of companies dominate the shipments. MANKIND PHARMA LIMITED holds the largest share at 12.4% (export value: $4.9M). Close behind, SENTISS PHARMA PRIVATE LIMITED (10.0%, $3.9M). SUN PHARMACEUTICAL INDUSTRIES LIMITED (10.0%, $3.9M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Tobramycin? Top Manufacturers & Their Buyers
Flow of Tobramycin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Tobramycin Supplier Network — Key Market Intelligence
The Tobramycin export market from India is led by MANKIND PHARMA LIMITED, which alone commands a 12.4% share, shipping $4.9M worth of product across 78 shipments. The second-largest exporter, SENTISS PHARMA PRIVATE LIMITED, contributes $3.9M (10.0%) to the overall market. Combined, the top two suppliers alone account for 22.5% of all Tobramycin exports, indicating a relatively concentrated supply base.
Across all 283 tracked manufacturers, the total Tobramycin export value stands at $39.2M from 2.7K shipments. The market average shipment value is $14.7K. The single largest buyer relationship in terms of trade value is LLC SENTISS RUS, receiving $3.4M worth of product.
The combined buyer network spans 15 named purchasing companies, including LIFESTAR PHARMA LLC, LIFESTAR PHARMA LLCC/O RXCROSSROADS, NORTHSTAR RX LLC, LLC SENTISS RUS, SUN PHARMACEUTICAL INDUSTRIES INC and 10 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MANKIND PHARMA LIMITED
MANKIND PHARMA LIMITED is the first-largest Tobramycin exporter from India, with a market share of 12.4% and a total export value of $4.9M across 78 shipments. Their average shipment value of $62.6K is above the market average of $14.7K, suggesting premium or bulk contract pricing.
MANKIND PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• LIFESTAR PHARMA LLC — $1.8M across 28 shipments (36.2% of this supplier's total exports)
• LIFESTAR PHARMA LLC — $1.2M across 20 shipments (25.2% of this supplier's total exports)
• LIFESTAR PHARMA LLCC/O RXCROSSROADS — $829.6K across 13 shipments (17.0% of this supplier's total exports)
• NORTHSTAR RX LLC — $556.2K across 9 shipments (11.4% of this supplier's total exports)
• LIFESTAR PHARMA LLCC/O RXCROSSROADS — $496.8K across 8 shipments (10.2% of this supplier's total exports)
Key Insight: MANKIND PHARMA LIMITED's per-shipment value of $62.6K is 327% above the market average of $14.7K, consistent with large-order contracts or value-added formulations.
2SENTISS PHARMA PRIVATE LIMITED
SENTISS PHARMA PRIVATE LIMITED is the second-largest Tobramycin exporter from India, with a market share of 10.0% and a total export value of $3.9M across 60 shipments. Their average shipment value of $65.5K is above the market average of $14.7K, suggesting premium or bulk contract pricing.
SENTISS PHARMA PRIVATE LIMITED serves 4 named buyers in our database. LLC SENTISS RUS is the dominant customer, accounting for 87.1% of this supplier's tracked business. Top customers include:
• LLC SENTISS RUS — $3.4M across 52 shipments (87.1% of this supplier's total exports)
• LLC SENTISS RUS — $303.0K across 5 shipments (7.7% of this supplier's total exports)
• LLC SENTISS RUS — $131.3K across 2 shipments (3.3% of this supplier's total exports)
• LLC SENTISS RUS — $72.6K across 1 shipments (1.8% of this supplier's total exports)
Key Insight: SENTISS PHARMA PRIVATE LIMITED's per-shipment value of $65.5K is 347% above the market average of $14.7K, consistent with large-order contracts or value-added formulations.
3SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the third-largest Tobramycin exporter from India, with a market share of 10.0% and a total export value of $3.9M across 77 shipments. Their average shipment value of $50.7K is above the market average of $14.7K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• SUN PHARMACEUTICAL INDUSTRIES INC — $1.3M across 25 shipments (32.3% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $1.2M across 23 shipments (30.3% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIES INC — $813.8K across 16 shipments (20.8% of this supplier's total exports)
• SUN PHARMA ANZ PTY LTD — $441.6K across 9 shipments (11.3% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIES INC — $206.2K across 4 shipments (5.3% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $50.7K is 246% above the market average of $14.7K, consistent with large-order contracts or value-added formulations.
4GLAND PHARMA LTD
GLAND PHARMA LTD is the fourth-largest Tobramycin exporter from India, with a market share of 8.5% and a total export value of $3.3M across 35 shipments. Their average shipment value of $94.9K is above the market average of $14.7K, suggesting premium or bulk contract pricing.
GLAND PHARMA LTD serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES is the dominant customer, accounting for 79.0% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCE SERVICES — $2.6M across 28 shipments (79.0% of this supplier's total exports)
• STERIMAX INC — $373.2K across 4 shipments (11.2% of this supplier's total exports)
• NORTHSTAR DISTIBUTIO — $122.0K across 1 shipments (3.7% of this supplier's total exports)
• INTEGRATED COMMERCIA — $115.1K across 1 shipments (3.5% of this supplier's total exports)
• RAINBOW GOLD, INC — $86.2K across 1 shipments (2.6% of this supplier's total exports)
Key Insight: GLAND PHARMA LTD's per-shipment value of $94.9K is 547% above the market average of $14.7K, consistent with large-order contracts or value-added formulations.
5MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the fifth-largest Tobramycin exporter from India, with a market share of 5.6% and a total export value of $2.2M across 45 shipments. Their average shipment value of $48.4K is above the market average of $14.7K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ALPHAPHARM PTY LTD — $620.3K across 13 shipments (28.5% of this supplier's total exports)
• MYLAN INSTITUTIONAL INC — $607.1K across 13 shipments (27.9% of this supplier's total exports)
• MYLAN INSTITUTIONAL INC — $523.1K across 11 shipments (24.0% of this supplier's total exports)
• MYLAN AUSTRALIA — $265.9K across 5 shipments (12.2% of this supplier's total exports)
• MYLAN INSTITUTIONAL INC — $161.8K across 3 shipments (7.4% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $48.4K is 230% above the market average of $14.7K, consistent with large-order contracts or value-added formulations.
6GLAND PHARMA LIMITED
GLAND PHARMA LIMITED is the fifth-largest Tobramycin exporter from India, with a market share of 2.4% and a total export value of $944.5K across 17 shipments. Their average shipment value of $55.6K is above the market average of $14.7K, suggesting premium or bulk contract pricing.
GLAND PHARMA LIMITED serves 3 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES is the dominant customer, accounting for 80.8% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCE SERVICES — $763.0K across 14 shipments (80.8% of this supplier's total exports)
• INTEGRATED COMMERCIA — $111.5K across 2 shipments (11.8% of this supplier's total exports)
• STERIMAX INC — $70.0K across 1 shipments (7.4% of this supplier's total exports)
Key Insight: GLAND PHARMA LIMITED's per-shipment value of $55.6K is 279% above the market average of $14.7K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Tobramycin Flows
Once Tobramycin leaves the manufacturing plants of companies like MANKIND PHARMA LIMITED and SENTISS PHARMA PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $39.2M. United States absorbs the largest share at 62.3% ($24.5M), followed by Russia (15.3%) and Belgium (8.8%).
In United States — the top destination — named importers include LIFESTAR PHARMA LLC, EVERSANA LIFE SCIENCE SERVICES, RX CROSSROADS 3PL LLC. In Russia, key buyers are LLC SENTISS RUS, OOO"JODAS EXPOIM".
This geographic spread reflects Tobramycin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Tobramycin Go? Top Importing Countries & Their Buyers
Trade flow of Tobramycin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Tobramycin imports from India, with a total trade value of $24.5M across 239 shipments — representing a 62.3% share of all Tobramycin exports. The average shipment value of $102.4K is above the global average of $14.7K, indicating high-value procurement contracts or branded formulations. This market is served by 13 tracked buyers.
Named Tobramycin importers in United States: LIFESTAR PHARMA LLC is the largest buyer, accounting for 20.6% ($5.0M) of this market's total imports.
• LIFESTAR PHARMA LLC — $5.0M (20.6% of United States's total)
• EVERSANA LIFE SCIENCE SERVICES — $4.3M (17.5% of United States's total)
• RX CROSSROADS 3PL LLC — $2.0M (8.2% of United States's total)
Key Insight: United States's per-shipment average of $102.4K (598% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Tobramycin imports from India.
2Russia
Russia ranks as the second-largest destination for Tobramycin imports from India, with a total trade value of $6.0M across 48 shipments — representing a 15.3% share of all Tobramycin exports. The average shipment value of $125.1K is above the global average of $14.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Tobramycin importers in Russia: LLC SENTISS RUS is the largest buyer, accounting for 67.6% ($4.1M) of this market's total imports.
• LLC SENTISS RUS — $4.1M (67.6% of Russia's total)
• OOO"JODAS EXPOIM" — $1.1M (17.5% of Russia's total)
Key Insight: Russia's per-shipment average of $125.1K (753% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Tobramycin imports from India.
3Belgium
Belgium ranks as the third-largest destination for Tobramycin imports from India, with a total trade value of $3.5M across 62 shipments — representing a 8.8% share of all Tobramycin exports. The average shipment value of $56.0K is above the global average of $14.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Tobramycin importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 73.0% ($2.5M) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $2.5M (73.0% of Belgium's total)
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $934.7K (26.9% of Belgium's total)
Key Insight: Belgium's per-shipment average of $56.0K (282% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Tobramycin imports from India.
4Australia
Australia ranks as the fourth-largest destination for Tobramycin imports from India, with a total trade value of $1.6M across 18 shipments — representing a 4.0% share of all Tobramycin exports. The average shipment value of $87.5K is above the global average of $14.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Tobramycin importers in Australia: ALPHAPHARM PTY LTD is the largest buyer, accounting for 39.4% ($620.3K) of this market's total imports.
• ALPHAPHARM PTY LTD — $620.3K (39.4% of Australia's total)
• SUN PHARMA ANZ PTY LTD — $606.4K (38.5% of Australia's total)
Key Insight: Australia's per-shipment average of $87.5K (497% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Tobramycin imports from India.
5Vietnam
Vietnam ranks as the fifth-largest destination for Tobramycin imports from India, with a total trade value of $668.4K across 0 shipments — representing a 1.7% share of all Tobramycin exports. The average shipment value of $668.4K is above the global average of $14.7K, indicating high-value procurement contracts or branded formulations.
Key Insight: Vietnam's per-shipment average of $668.4K (4458% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Vietnam is a key market for Tobramycin imports from India.
People Also Ask — Tobramycin Supplier & Trade Network
Who are the top suppliers of Tobramycin from India?+
Which companies buy Tobramycin from Indian manufacturers?+
Where does Tobramycin exported from India go?+
What is the market share of the top Tobramycin supplier from India?+
What is the average shipment value for Tobramycin exports from India?+
Is Tobramycin manufactured in India and exported globally?+
Which country imports the most Tobramycin from India?+
Who are the buyers of Tobramycin in Russia?+
How concentrated is the Tobramycin supplier market in India?+
How do I find verified buyers for Tobramycin in specific countries?+
Tobramycin Trade Network — Key Takeaways
- 1MANKIND PHARMA LIMITED is India's dominant Tobramycin exporter with a 12.4% market share and $4.9M in total exports — making it the single most important sourcing entity in this market.
- 2The top 283 suppliers collectively account for 48.8% of all tracked Tobramycin exports, with a combined trade value of $39.2M.
- 3United States is the largest destination market, absorbing 62.3% of India's Tobramycin exports ($24.5M). Russia (15.3%) and Belgium (8.8%) follow.
- 4With 2.7K total shipments averaging $14.7K each, the Tobramycin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include LIFESTAR PHARMA LLC, LIFESTAR PHARMA LLC, LLC SENTISS RUS, LLC SENTISS RUS — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 134 countries
Network value: $39.2M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tobramycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Tobramycin.
- 2.Flow Mapping: 283 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,676 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 134 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,676 Verified Shipments
283 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists